硫唑嘌呤诱发炎症性肠病患者的肝炎。 - Suppr

Suppr

超能文献

Azathioprine induced hepatitis in patients with inflammatory bowel disease.

作者信息

Srirajaskanthan Rajaventhan, Valliani Dilshad

出版信息

Int J Clin Pharm. 2011 Oct;33(5):724-5. doi: 10.1007/s11096-011-9557-3. Epub 2011 Sep 3.

DOI:10.1007/s11096-011-9557-3

PMID:21892694

Abstract

摘要

相似文献

Azathioprine induced hepatitis in patients with inflammatory bowel disease.

Int J Clin Pharm. 2011 Oct;33(5):724-5. doi: 10.1007/s11096-011-9557-3. Epub 2011 Sep 3.

Nodular regenerative hyperplasia of the liver secondary to azathioprine in a patient with inflammatory bowel disease.

N Z Med J. 2010 Apr 30;123(1313):74-6.

[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects].

Dtsch Med Wochenschr. 2003 Feb 21;128(8):378-85. doi: 10.1055/s-2003-37378.

Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity.

Gastroenterology. 2002 Mar;122(3):838-9. doi: 10.1053/gast.2002.32124.

Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.

Inflamm Bowel Dis. 2003 Nov;9(6):389-91; discussion 392-3. doi: 10.1097/00054725-200311000-00008.

Optimizing thiopurine therapy in inflammatory bowel disease.

Inflamm Bowel Dis. 2011 Jun;17(6):1428-35. doi: 10.1002/ibd.21494. Epub 2010 Oct 14.

Monitoring of AZA/6-MP treatment in children with IBD is necessary.

Inflamm Bowel Dis. 2003 Nov;9(6):386-8; discussion 392-3. doi: 10.1097/00054725-200311000-00007.

Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.

Clin Gastroenterol Hepatol. 2006 Jan;4(1):44-9. doi: 10.1016/j.cgh.2005.10.019.

[Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity].

Rev Esp Enferm Dig. 2002 Oct;94(10):635-6.

Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine.

Aliment Pharmacol Ther. 2002 Mar;16(3):389-98. doi: 10.1046/j.1365-2036.2002.01177.x.

本文引用的文献

Azathioprine-induced severe cholestatic hepatitis in patient carrying TPMT*3C polymorphism.

Pharm World Sci. 2010 Dec;32(6):701-3. doi: 10.1007/s11096-010-9443-4. Epub 2010 Oct 23.

Severe cholestatic acute hepatitis following azathioprine therapy in a patient with ulcerative pancolitis.

Dig Liver Dis. 2009 Dec;41(12):914-5. doi: 10.1016/j.dld.2009.03.004. Epub 2009 Apr 18.

Severe cholestatic hepatitis caused by azathioprine.

Immunopharmacol Immunotoxicol. 2005;27(1):77-83. doi: 10.1081/iph-51744.

Cholestatic hepatocellular injury with azathioprine: a case report and review of the mechanisms of hepatotoxicity.

Can J Gastroenterol. 1998 Oct;12(7):479-83. doi: 10.1155/1998/294752.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验